These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17145863)

  • 41. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
    Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
    Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
    Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
    Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
    Liu S; Ren S; Howell P; Fodstad O; Riker AI
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
    Schultz J; Ibrahim SM; Vera J; Kunz M
    Mol Cancer; 2009 Jul; 8():53. PubMed ID: 19642975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA methylation contributes toward silencing of antioncogenic microRNA-203 in human and canine melanoma cells.
    Noguchi S; Mori T; Nakagawa T; Itamoto K; Haraguchi T; Mizuno T
    Melanoma Res; 2015 Oct; 25(5):390-8. PubMed ID: 26225581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.
    Wong CM; Lee JM; Ching YP; Jin DY; Ng IO
    Cancer Res; 2003 Nov; 63(22):7646-51. PubMed ID: 14633684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic and genetic alterations of p33ING1b in ovarian cancer.
    Shen DH; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Ip P; Cheung AN
    Carcinogenesis; 2005 Apr; 26(4):855-63. PubMed ID: 15677627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation silencing of the Apaf-1 gene in acute leukemia.
    Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
    Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
    Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
    Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
    Liu X; Dai X; Wu B
    Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.
    Lindner DJ; Wu Y; Haney R; Jacobs BS; Fruehauf JP; Tuthill R; Borden EC
    Matrix Biol; 2013 Mar; 32(2):123-32. PubMed ID: 23202046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
    Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF
    Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.
    Massoumi R; Kuphal S; Hellerbrand C; Haas B; Wild P; Spruss T; Pfeifer A; Fässler R; Bosserhoff AK
    J Exp Med; 2009 Jan; 206(1):221-32. PubMed ID: 19124656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
    Mithani SK; Smith IM; Califano JA
    Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silencing of metallothionein 1A gene in melanoma.
    Nobeyama Y; Nakagawa H
    J Dermatol Sci; 2017 Nov; 88(2):232-237. PubMed ID: 28764861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma.
    Muthusamy V; Premi S; Soper C; Platt J; Bosenberg M
    J Invest Dermatol; 2013 Jul; 133(7):1827-33. PubMed ID: 23364479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity.
    Wang H; Lee S; Nigro CL; Lattanzio L; Merlano M; Monteverde M; Matin R; Purdie K; Mladkova N; Bergamaschi D; Harwood C; Syed N; Szlosarek P; Briasoulis E; McHugh A; Thompson A; Evans A; Leigh I; Fleming C; Inman GJ; Hatzimichael E; Proby C; Crook T
    Br J Cancer; 2012 Apr; 106(8):1446-52. PubMed ID: 22454080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma.
    Bonazzi VF; Nancarrow DJ; Stark MS; Moser RJ; Boyle GM; Aoude LG; Schmidt C; Hayward NK
    PLoS One; 2011; 6(10):e26121. PubMed ID: 22028813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.